Premium
Check Cap Ltd (CHEK)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for... Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0249 | -3.13246949302 | 0.7949 | 0.8227 | 0.7325 | 18805 | 0.76654575 | CS |
| 4 | -0.102 | -11.6972477064 | 0.872 | 1.52 | 0.71 | 391803 | 1.01768323 | CS |
| 12 | 0.21 | 37.5 | 0.56 | 3.04 | 0.56 | 1576662 | 1.80248621 | CS |
| 26 | -1.04 | -57.4585635359 | 1.81 | 3.04 | 0.56 | 708860 | 1.7917704 | CS |
| 52 | -1.19 | -60.7142857143 | 1.96 | 3.45 | 0.56 | 412320 | 1.89927453 | CS |
| 156 | -7.23 | -90.375 | 8 | 9.2 | 0.56 | 294013 | 4.15709173 | CS |
| 260 | -25.83 | -97.1052631579 | 26.6 | 89.8 | 0.56 | 2306799 | 28.6863227 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
